Researchers in Madison plan to test a personalized cell therapy for viral infections in bone marrow transplant patients — a first for Wisconsin.

An upcoming clinical trial in Madison, approved by the FDA, will include both adults and children. About 20 participants are expected.

Dr. Inga Hofmann is principal investigator for the trial and medical director for the UW Program for Advanced Cell Therapy. She says the trial is set to enroll patients immediately through a partnership with UW Health.